Generation of induced pluripotent stem cells (NIMHi001-A) from a Parkinson's disease patient of East Indian ethnicity carrying LRRK2 I1371V variant
Summary
Mutations in the Leucine Repeat Rich Kinase-2 (LRRK2) gene have been reported in familial Parkinson's disease (PD) cases. We have generated induced pluripotent stem cells (iPSCs) using Sendai-virus reprogramming-method from peripheral blood mononuclear cells of PD-patient of East-Indian ethnicity carrying the I1371V mutation in LRRK2 gene. PD diagnosis was performed using Unified Parkinson's Disease rating scale (UPDRS) score and confirmed by [18F]fluoro-l-dopa [F-DOPA] positron emission tomography (F-DOPA PET). The iPSC line was characterized for self-renewal and pluripotency. This cellular model will provide a valuable resource not only for drug-screening platform but also to understand the pathophysiology of this disease. Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.
| Authors | Datta I, Sowmithra, Jagtap S, Potdar C, Yadav R, Pal P |
|---|---|
| Journal | Stem cell research |
| Publication Date | 2020 Apr;44:101768 |
| PubMed | 32244201 |
| DOI | 10.1016/j.scr.2020.101768 |